Literature DB >> 6278355

Chronic clonazepam administration induces benzodiazepine receptor subsensitivity.

J N Crawley, P J Marangos, J Stivers, F K Goodwin.   

Abstract

Clonazepam and chlordiazepoxide were administered chronically in increasing doses for three weeks in two different strains of mice. Forebrain [3H]diazepam binding was assayed in groups of mice sacrificed at 2, 26, 50 hr and 10 days following the last dose. Scatchard and single point analyses revealed a significant decrease in the number of [3H]diazepam binding sites [Bmax] which persisted for at least two days following chronic clonazepam treatment. The Bmax changes observed following chlordiazepoxide treatment were less pronounced than those elicited by clonazepam. No significant changes in receptor binding affinity (Kd) were detected with either drug. In the clonazepam-treated animals, Bmax values returned to normal by day 10 after drug treatment. Chronic benzodiazepine administration therefore induced a decrease in the apparent number of benzodiazepine binding sites in the mouse forebrain. The magnitude and duration of the observed subsensitivity appears to depend on the potency of the administered benzodiazepine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278355     DOI: 10.1016/0028-3908(82)90216-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  The effects of two anticonvulsants on amino acid levels in the developing rat cerebellum.

Authors:  R S Hannah; A W Spira; S H Roth
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

2.  Lorazepam discontinuation promotes 'inverse agonist' effects of benzodiazepines.

Authors:  A Schatzki; F Lopez; D J Greenblatt; R I Shader; L G Miller
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

Authors:  K Aranko; M J Mattila; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

4.  Decreased expression of gamma-aminobutyric acid type A/benzodiazepine receptor beta subunit mRNAs in brain of flurazepam-tolerant rats.

Authors:  T J Zhao; T H Chiu; H C Rosenberg
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

5.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

6.  The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.

Authors:  G Tedeschi; A N Griffiths; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

Review 7.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

8.  Functional tolerance to lorazepam in the rat.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Effects of chronic melatonin administration on GABA and diazepam binding in rat brain.

Authors:  L P Niles; D S Pickering; M A Arciszewski
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

10.  Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors.

Authors:  S Ishihara; M Hiramatsu; T Kameyama; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.